Login / Signup

SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption.

Dillon MintoffD PisaniN LivoriI Said-HuntingfordG Baldacchino
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • binding protein
  • adverse drug
  • coronavirus disease
  • electronic health record